Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should ...
Barchart on MSN7d
3 Safe Haven Stocks to Own in an Unpredictable Market
The stock market had a great start to 2024, with the S&P 500 Index ($SPX) ending the first quarter with 10.2% gains - its ...
Zacks.com on MSN8d
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
Boston Scientific Corporation BSX is scheduled to report first-quarter 2024 results on Apr 24, before the opening bell. In ...
Barchart on MSN13h
Stocks Mixed on Rising Bond Yields
Strength in technology stocks is supportive of the overall market. Tesla is up more than +11% despite reporting ...
Barchart on MSN15h
Strong Tech Earnings Lift Stocks
Strength in technology stocks is leading the broader market higher. Tesla is up more than +12% despite reporting ...
The Gazette1d
Stock market today: Asian benchmarks mostly slide as investors focus on earnings
They'll likely need to deliver fatter profits if they want their stock prices to rise ... reporting stronger profit and ...
Texas Instruments stock pops on Q2 revenue outlook
Texas Instruments (TXN) posted first quarter results that topped Wall Street estimates, but it's the company's second quarter ...
Zee Business3h
S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
Drugmaker Biogen (BIIB.O) gained 4.5 per cent after it beat first-quarter profit expectations, while Boston Scientific (BSX.N ...
Seeking Alpha10d
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Boston Scientific has guided for 2024 revenue of ... Needham also noted that ResMed’s stock has been under pressure due to ongoing concerns that the popularity of GLP-1 weight loss drugs will ...